This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Insilico Medicine Hong Kong Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Aleksandr Aliper
Introduction
Aleksandr Aliper is a notable inventor based in Ramenskoye, Russia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors for the treatment of various diseases. With a total of 1 patents, his work is paving the way for new therapeutic options.
Latest Patents
Aliper's latest patents focus on the development of analogs for the treatment of disease. The disclosures provide TNIK and/or MAP4K4 kinases inhibitors, which are crucial for treating various conditions. The patents detail kinase inhibitors with specific structural formulas, including Formula (A), (A*), (I), (IIA), or (IIB). Additionally, the patents describe pharmaceutical compositions that incorporate these compounds and methods for their use in treating diseases.
Career Highlights
Aleksandr Aliper is currently associated with Insilico Medicine Hong Kong Limited, where he continues to innovate in the field of drug development. His expertise in kinase inhibitors has positioned him as a key player in the pharmaceutical industry.
Collaborations
Aliper collaborates with notable colleagues, including Aleksandrs Zavoronkovs and Vladimir Aladinskiy. Their combined efforts contribute to advancing research and development in innovative therapeutic solutions.
Conclusion
Aleksandr Aliper's work exemplifies the impact of innovation in medicine, particularly through his patents on kinase inhibitors. His contributions are essential for the ongoing development of effective treatments for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile